EBL board reconstitution: 7 directors appointed under Scheme of Arrangement

Strategic Transactions View source PDF Explain this filing

INDIAGLYCO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.2%Reaction day

₹1146.00

prior close

₹1155.00

announcement price

After-mkt

timing

Nifty Microcap 250market+0.3%+3.9% vs market

Breweries & Distilleries peers, median of 25sector-0.4%+4.6% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty Microcap 250 and 4.6 pts more than its Breweries & Distilleries peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.1

10m

-0.8

15m

+0.3

30m

+0.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.2+0.3+3.9-0.4+4.6

Next day

+2.2-0.2+2.4+0.0+2.2

+4.0+0.4+3.6+0.8+3.2

+5.0+0.2+4.8-1.0+6.0

+2.4+0.5+2.0-0.5+3.0

+0.1+0.8-0.7-1.3+1.4

-79.4-0.8-78.6-1.1-78.3

15d

-75.5-2.1-73.4-6.4-69.2

-73.0+0.2-73.3-5.9-67.2

-75.1-9.2-66.0-13.9-61.2

—————

UpDownMarket · Nifty Microcap 250Sector · Breweries & Distilleries peers, median of 25Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

IGL shared board changes at Ennature Bio Pharma Limited (EBL) under its ongoing Scheme of Arrangement. EBL board on 21 Aug 2026 appointed 7 directors: Pragya Bhartia Barwale as Managing Director for 5 years, U.S. Bhartia and Pooja Jhaver as Non-Executive Directors, plus 4 Independent Directors (Memani, Wassan, Agarwal, Nirula) for 3-year terms. Bhartia family members lead EBL. Subject to shareholder approval.

Likely market impact

Procedural update under ongoing scheme; signals continued progress in EBL corporate setup ahead of arrangement with IGL.